STOCK TITAN

Inmode Ltd. Stock Price, News & Analysis

INMD Nasdaq

Welcome to our dedicated page for Inmode Ltd. news (Ticker: INMD), a resource for investors and traders seeking the latest updates and insights on Inmode Ltd. stock.

InMode Ltd. (INMD) delivers innovative radiofrequency-based solutions for minimally invasive aesthetic treatments. This news hub provides investors and medical professionals with essential updates on the company's strategic developments, technological advancements, and market leadership in medical aesthetics.

Access real-time announcements including quarterly earnings, product launch details, regulatory milestones, and partnership agreements. Our curated collection features press releases covering facial/body contouring innovations, clinical study results, and intellectual property developments central to INMD's growth strategy.

Key updates include FDA-cleared device announcements, global expansion initiatives, and R&D breakthroughs in RF energy applications. Bookmark this page for verified information on corporate governance changes, manufacturing updates, and industry conference participation directly from InMode's communications team.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.03%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10%
Tags
-
Rhea-AI Summary

InMode Ltd. (INMD) announced the expected release of its first-quarter 2023 financial results on May 2, 2023, before the Nasdaq market opens. Preliminary estimates indicate revenue between $105.7 million and $105.9 million, and non-GAAP earnings per diluted share in the range of $0.50 to $0.51. The company anticipates a non-GAAP gross margin between 83% and 85%. The management team will host a conference call at 8:30 a.m. Eastern Time to discuss the financial results. Investors are encouraged to register for the call ahead of time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.13%
Tags
-
Rhea-AI Summary

InMode Ltd. (NASDAQ: INMD) announced on March 13, 2023, that it does not hold cash or securities at Silicon Valley Bank. The company keeps its cash and non-insured deposits in U.S. money center banks and major Israeli financial institutions. Consequently, InMode does not anticipate any operational impact from the bank's closure. The company will continue to monitor potential effects on its suppliers, vendors, and other partners.

InMode is recognized for its innovative medical technologies, particularly those utilizing radiofrequency (RF) technology, serving various medical fields including plastic surgery and dermatology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.13%
Tags
none
Rhea-AI Summary

InMode Ltd. (NASDAQ: INMD), a global leader in innovative medical technologies, announced that its CFO Yair Malca and CMO Spero Theodorou will present at the Barclays Global Health Conference in Miami on March 15, 2023. The presentation is set for 9:30 am ET and will be moderated by equity research analyst Matt Miksic. Interested parties can access the webcast via InMode's Investor Relations website. InMode will also hold one-on-one investor meetings that day. For further details, visit the investor relations site.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.41%
Tags
conferences
-
Rhea-AI Summary

InMode Ltd. (Nasdaq: INMD) reported record financial results for Q4 and FY 2022. Q4 revenue reached $133.6 million, a 21% increase from Q4 2021, with 83% from surgical technology platforms. GAAP net income for Q4 was $37.7 million, while non-GAAP net income hit $66.4 million. For the full year, revenues reached $454.3 million, a 27% increase, with GAAP net income of $161.5 million. Looking ahead, InMode forecasts revenue between $525 million and $530 million for 2023. Investors can expect a non-GAAP EPS of $2.58 to $2.60.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.5%
Tags
-
Rhea-AI Summary

InMode Ltd. (Nasdaq: INMD) is set to announce its financial results for Q4 and the full year 2022 on February 14, 2023. Preliminary estimates indicate record revenues between $133.2 million and $133.4 million for Q4 2022, and $453.9 million to $454.1 million for the full year. Non-GAAP earnings per diluted share are expected to be $0.73 to $0.74 for Q4 and $2.38 to $2.39 for 2022. Additionally, the company projects 2023 revenues between $525 million and $530 million. InMode will hold a conference call on February 14 at 8:30 a.m. ET to discuss the results.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.62%
Tags
Rhea-AI Summary

InMode Ltd. (Nasdaq: INMD) announced that its leadership team, including Moshe Mizrahy (CEO), Yair Malca (CFO), and Spero Theodorou (CMO), will present at the 25th Annual Needham Growth Conference on Jan. 12, 2023. The event, moderated by Mike Matson, starts at 10:15 am Eastern Time and will be accessible via webcast on InMode's Investor Relations website. Additionally, InMode will conduct in-person meetings on Jan. 11 and virtual meetings on Jan. 12.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.23%
Tags
conferences

FAQ

What is the current stock price of Inmode Ltd. (INMD)?

The current stock price of Inmode Ltd. (INMD) is $15.15 as of October 3, 2025.

What is the market cap of Inmode Ltd. (INMD)?

The market cap of Inmode Ltd. (INMD) is approximately 977.2M.
Inmode Ltd.

Nasdaq:INMD

INMD Rankings

INMD Stock Data

977.21M
53.51M
15.35%
59.25%
5.46%
Medical Devices
Healthcare
Link
Israel
Yokne'am